biotechnology / cancer therapeutics / Cancer Treatment / pharmaceutical / healthcare / exploratory algorithms / /
MedicalCondition
Such disease / tumor / node-positive breast cancer / DF / cancer / tumors / disease / colorectal cancer / human tumors / valid disease / molecularly targeted cancer / early cancer / experimental tumor / diseases / breast cancer / kidney cancer / B-cell lymphoma receiving cyclophosphamide/doxorubicin/ vincristine/prednisone chemotherapy / /
MedicalTreatment
cancer therapeutics / chemotherapy / /
Organization
National Cancer Institute / Division of Cancer Treatment & Diagnosis / US Food and Drug Administration / American Society / /
Person
K. Dobbin / Simon R. Sample / Simon R. On / Richard Simon / Ann Oncol / Simon R. Targets / Simon R. Diagnostic / / /
A Checklist for Evaluating Reports of Expression Profiling for Treatment Selection Richard Simon, DSc Dr. Simon is Chief, Biometric Research Branch in the Division of Cancer Treatment & Diagnosis at the National Cancer